Advertisement
Screener

Nuo Therapeutics, Inc. (AURX) Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

Nuo Therapeutics, Inc. Deferred Revenue

Nuo Therapeutics, Inc. (AURX) had Deferred Revenue of $1.00 million as of 2015-12-31, per its 10-Q filed 2016-10-24.

Discontinued › Balance Sheet › Liabilities

us-gaap:DeferredRevenue · last filed 2016-10-24

  • 2015-12-31: Deferred Revenue $1.00M.
  • 2013-12-31: Deferred Revenue $338.61K.
  • 2013-09-30: Deferred Revenue $2.10M.
Period endDeferred Revenue
2015-12-31$1.00M
10-Q · filed 2016-10-24
2013-12-31$338.61K
10-K · filed 2014-03-31
2013-09-30$2.10M
10-Q · filed 2013-11-12